DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 43 filers reported holding DEPOMED INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $33,000 | -5.7% | 45,000 | 0.0% | 0.00% | – |
| Q1 2019 | $35,000 | +16.7% | 45,000 | 0.0% | 0.00% | – |
| Q4 2018 | $30,000 | -18.9% | 45,000 | 0.0% | 0.00% | – |
| Q2 2018 | $37,000 | -98.5% | 45,000 | -98.2% | 0.00% | -100.0% |
| Q1 2017 | $2,397,000 | +34.4% | 2,567,000 | +63.8% | 0.00% | +50.0% |
| Q4 2016 | $1,784,000 | -7.5% | 1,567,000 | +15.7% | 0.00% | 0.0% |
| Q3 2016 | $1,928,000 | -82.1% | 1,354,000 | -84.8% | 0.00% | -85.7% |
| Q2 2016 | $10,761,000 | +80.7% | 8,916,000 | +39.2% | 0.01% | +55.6% |
| Q1 2016 | $5,955,000 | -8.0% | 6,403,000 | +11.8% | 0.01% | +12.5% |
| Q4 2015 | $6,474,000 | -55.9% | 5,729,000 | -53.5% | 0.01% | -55.6% |
| Q3 2015 | $14,668,000 | +431.4% | 12,326,000 | +489.5% | 0.02% | +500.0% |
| Q1 2015 | $2,760,000 | -3.4% | 2,091,000 | -21.7% | 0.00% | 0.0% |
| Q4 2014 | $2,857,000 | -12.9% | 2,670,000 | -14.6% | 0.00% | 0.0% |
| Q3 2014 | $3,281,000 | – | 3,125,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 4,500,000 | $3,964,000 | 2.82% |
| Telemetry Investments, L.L.C. | 5,000,000 | $4,388,000 | 2.06% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 23,500,000 | $20,904,000 | 1.92% |
| CQS Cayman LP | 17,000,000 | $15,174,000 | 1.04% |
| Sonora Investment Management, LLC | 5,275,000 | $4,639,890,000 | 0.88% |
| LINDEN ADVISORS LP | 19,150,000 | $16,881,000 | 0.71% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 47,500,000 | $41,919,000,000 | 0.69% |
| MACKAY SHIELDS LLC | 14,016,000 | $12,344,000 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,933,000 | $24,614,000 | 0.47% |
| Senvest Management, LLC | 5,000,000 | $4,419,000 | 0.35% |